Mounting scientific interest in psychedelics has arrived at the highest levels of presidency. The Meals and Drug Administration in 2018 granted psilocybin “breakthrough therapy” status for key depressive disorder, a designation that paved just how for scientific trials.The U.S. continue to restricts methadone prescribing and dispensing much mor